Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Noradrenaline Bitartrate

    Client Email Product

    Noradrenaline Bitartrate

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    26
    US DMFs Filed

    US DMFs Filed

    8
    CEP/COS Certifications

    CEP/COS Certifications

    6
    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    5
    Other Suppliers

    Other Suppliers

    19
    API REF. PRICE (USD / KG)
    24,285

    API Market Place

    17
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    25
    Europe

    Europe

    7
    Canada

    Canada

    5
    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    7
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    4
    EXCIPIENTS
    2
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    21

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    25
    REF STANDARD

    EDQM

    0

    USP

    1

    JP

    3

    Other Listed Suppliers

    1
    SERVICES

    0

    Full View ScreenFull Screen View
    Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.
    Baxter Expands Pharmaceuticals Portfolio with New Injectable Products in the U.S.

    https://www.baxter.com/baxter-newsroom/baxter-expands-pharmaceuticals-portfolio-new-injectable-products-us#:~:text=Baxter%20offers%20the%20first%20and,Vasopressin%20in%20a%20flexible%20container.

    PRESS RELEASE
    12 Apr 2024
    Share Share
    Enforcement Report - Week of February 28, 2024
    Enforcement Report - Week of February 28, 2024

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2024-59068.pdf

    FDA
    28 Feb 2024
    Share Share
    FDA Confirms Paragraph IV Patent Litigation for Norepinephrine Bitartrate in 0.9 % Sodium Chloride
    FDA Confirms Paragraph IV Patent Litigation for Norepinephrine Bitartrate in 0.9 % Sodium Chloride

    https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-norepinephrine-bitartrate-in-09-sodium-chloride-34421.pdf

    FDA
    06 Dec 2023
    Share Share
    Enforcement Report - Week of April 19, 2023
    Enforcement Report - Week of April 19, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-19-2023-50304.pdf

    FDA
    19 Apr 2023
    Share Share
    Enforcement Report - Week of March 8, 2023
    Enforcement Report - Week of March 8, 2023

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf

    FDA
    08 Mar 2023
    Share Share
    Zydus gets USFDA nod to market generic blood pressure lowering drug
    Zydus gets USFDA nod to market generic blood pressure lowering drug

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-gets-usfda-nod-to-market-generic-blood-pressure-lowering-drug/articleshow/93022717.cms

    ECONOMIOC TIMES
    21 Jul 2022
    Share Share
    Zydus Pharma Generic Norepinephrine Bitartrate Receives Approval in the U.S.
    Zydus Pharma Generic Norepinephrine Bitartrate Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216341

    FDA
    19 Jul 2022
    Share Share
    Enforcement Report - Week of March 30, 2022
    Enforcement Report - Week of March 30, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-30-2022-1648618596.pdf

    FDA
    30 Mar 2022
    Share Share
    Enforcement Report - Week of March 02, 2022
    Enforcement Report - Week of March 02, 2022

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-02-2022-1646291076.pdf

    FDA
    02 Mar 2022
    Share Share
    FDA Approves Baxter's Ready-to-use Norepinephrine in Premix Formulation
    FDA Approves Baxter's Ready-to-use Norepinephrine in Premix Formulation

    https://www.businesswire.com/news/home/20210923005579/en

    BUSINESSWIRE
    23 Sep 2021
    Share Share
    Enforcement Report - Week of August 25, 2021
    Enforcement Report - Week of August 25, 2021

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-25-2021-1629867988.pdf

    FDA
    25 Aug 2021
    Share Share
    Breckenridge Pharmaceutical Launches Norepinephrine Bitartrate Injection USP
    Breckenridge Pharmaceutical Launches Norepinephrine Bitartrate Injection USP

    https://www.prnewswire.com/news-releases/breckenridge-pharmaceutical-inc-announces-launch-of-norepinephrine-bitartrate-injection-usp-generic-for-levophed-301359736.html

    PRNEWSWIRE
    20 Aug 2021
    Share Share
    Gland Pharma Ltd`s Generic Norepinephrine Bitartrate Receives Approval In US
    Gland Pharma Ltd`s Generic Norepinephrine Bitartrate Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214323

    FDA
    12 May 2021
    Share Share
    Fresenius Kabi USA`s Generic Norepinephrine Bitartrate Receives Approval In US
    Fresenius Kabi USA`s Generic Norepinephrine Bitartrate Receives Approval In US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211382

    FDA
    07 Nov 2020
    Share Share
    Enforcement Report - Week of January 1, 2020
    Enforcement Report - Week of January 1, 2020

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-1-2020-1577869200.pdf

    FDA
    01 Jan 2020
    Share Share
    Amneal Pharms' Generic Norepinephrine Bitartrate Receives Approval in US
    Amneal Pharms' Generic Norepinephrine Bitartrate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210839

    FDA
    17 Dec 2018
    Share Share
    Hikma Farmaceutica's Generic Norepinephrine Bitartrate Receives Approval in US
    Hikma Farmaceutica's Generic Norepinephrine Bitartrate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203662

    FDA
    08 Nov 2018
    Share Share
    Sandoz's Generic Norepinephrine Bitartrate Receives Approval in US
    Sandoz's Generic Norepinephrine Bitartrate Receives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211359

    FDA
    24 Oct 2018
    Share Share
    Mylan Labs' Generic Norepinephrine BitartrateReceives Approval in US
    Mylan Labs' Generic Norepinephrine BitartrateReceives Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211242

    FDA
    09 Oct 2018
    Share Share
    Enforcement Report - Week of July 25, 2018
    Enforcement Report - Week of July 25, 2018

    https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-July-25-2018-1532506531.pdf

    FDA
    25 Jul 2018
    Share Share
    Enforcement Report - Week of July 11, 2018
    Enforcement Report - Week of July 11, 2018

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-11-2018-1531283050.pdf

    FDA
    11 Jul 2018
    Share Share
    Enforcement Report - Week of November 1, 2017
    Enforcement Report - Week of November 1, 2017

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-1-2017-1509512060.pdf

    FDA
    01 Nov 2017
    Share Share
    Hospira Issues Voluntary Worldwide Recall For Lots of Hydromorphone HCl Injection, USP, CII, (2 mg/mL) 1mg/mL Vial, & Levophed®
    Hospira Issues Voluntary Worldwide Recall For Lots of Hydromorphone HCl Injection, USP, CII, (2 mg/mL) 1mg/mL Vial, & Levophed®

    https://www.pharmacompass.com/pdf/news/hospira-issues-voluntary-worldwide-recall-for-lots-of-hydromorphone-hcl-injection-usp-cii-2-mgml-1mgml-vial-levophed-1504322332.pdf

    FDA
    02 Sep 2017
    Share Share
    Enforcement Report - Week of August 16, 2017
    Enforcement Report - Week of August 16, 2017

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-16-2017-1502850779.pdf

    FDA
    16 Aug 2017
    Share Share
    Pharmedium Issues Voluntary Nationwide Recall of 4mg Norepinephrine Bitartrate
    Pharmedium Issues Voluntary Nationwide Recall of 4mg Norepinephrine Bitartrate

    http://www.fda.gov/Safety/Recalls/ucm479677.htm

    FDA
    31 Dec 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    Malladi Norepinephrine Bitartrate

    Access Virtual Booth

    Contact Supplier

    View Presentation

    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search